GENIXUS Trademark

Trademark Overview


On Monday, November 23, 2020, a trademark application was filed for GENIXUS with the United States Patent and Trademark Office. The USPTO has given the GENIXUS trademark a serial number of 90337589. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 25, 2024. This trademark is owned by Genixus, Corp.. The GENIXUS trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Contract manufacturing of pharmaceutical products; Contract manufacturing of pre-filled syringes containing pharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations

Pharmaceutical preparations and substances for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pre-filled syringes containing pharmaceutical preparations for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Injectable pharmaceuticals for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related dis...

Pharmaceutical research services; Research and development of pharmaceutical products; Scientific research in the field of pharmacy; Scientific research into the development of new products, namely pharmaceutical preparations; Testing services for assessing the efficacy and safety of pharmaceuticals; Development of products, namely pharmaceutical preparations; Scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; Industrial analysis and research services in the field of pharmaceuticals

General Information


Serial Number90337589
Word MarkGENIXUS
Filing DateMonday, November 23, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements


Goods and ServicesContract manufacturing of pharmaceutical products; Contract manufacturing of pre-filled syringes containing pharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations
Goods and ServicesPharmaceutical preparations and substances for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pre-filled syringes containing pharmaceutical preparations for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Injectable pharmaceuticals for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pre-filled syringes containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith
Goods and ServicesPharmaceutical research services; Research and development of pharmaceutical products; Scientific research in the field of pharmacy; Scientific research into the development of new products, namely pharmaceutical preparations; Testing services for assessing the efficacy and safety of pharmaceuticals; Development of products, namely pharmaceutical preparations; Scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; Industrial analysis and research services in the field of pharmaceuticals

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, January 28, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenixus, Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKannapolis, NC 28081

Party NameGenixus, Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKannapolis, NC 28081

Trademark Events


Event DateEvent Description
Thursday, November 26, 2020NEW APPLICATION ENTERED
Thursday, January 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 6, 2021ASSIGNED TO EXAMINER
Thursday, May 13, 2021NON-FINAL ACTION WRITTEN
Thursday, May 13, 2021NON-FINAL ACTION E-MAILED
Thursday, May 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 11, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 11, 2022SOU EXTENSION 1 FILED
Thursday, August 11, 2022SOU EXTENSION 1 GRANTED
Saturday, August 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 25, 2023SOU EXTENSION 2 FILED
Wednesday, January 25, 2023SOU EXTENSION 2 GRANTED
Friday, January 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 18, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 18, 2023SOU EXTENSION 3 FILED
Friday, August 18, 2023SOU EXTENSION 3 GRANTED
Tuesday, August 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 29, 2024WITHDRAWAL OF ATTORNEY GRANTED
Thursday, February 29, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, March 25, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED